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Abstract
To compare results for radiological prediction of pathological invasiveness in lung adenocarcinoma between radiologists and a deep
learning (DL) system.
Ninety patients (50 men, 40 women; mean age, 66 years; range, 40–88 years) who underwent pre-operative chest computed
tomography (CT) with 0.625-mm slice thickness were included in this retrospective study. Twenty-four cases of adenocarcinoma in
situ (AIS), 20 cases of minimally invasive adenocarcinoma (MIA), and 46 cases of invasive adenocarcinoma (IVA) were pathologically
diagnosed. Three radiologists of different levels of experience diagnosed each nodule by using previously documented CT ﬁndings to
predict pathological invasiveness. DL was structured using a 3-dimensional (3D) convolutional neural network (3D-CNN) constructed
with 2 successive pairs of convolution and max-pooling layers, and 2 fully connected layers. The output layer comprises 3 nodes to
recognize the 3 conditions of adenocarcinoma (AIS, MIA, and IVA) or 2 nodes for 2 conditions (AIS andMIA/IVA). Results fromDL and
the 3 radiologists were statistically compared.
No signiﬁcant differences in pathological diagnostic accuracy rates were seen between DL and the 3 radiologists (P>.11). Receiver
operating characteristic analysis demonstrated that area under the curve for DL (0.712) was almost the same as that for the
radiologist with extensive experience (0.714; P= .98). Comparedwith the consensus results from radiologists, DL offered signiﬁcantly
inferior sensitivity (P= .0005), but signiﬁcantly superior speciﬁcity (P= .02).
Despite the small training data set, diagnostic performance of DL was almost the same as the radiologist with extensive
experience. In particular, DL provided higher speciﬁcity than radiologists.
Abbreviations: 3D-CNN = 3-dimensional convolutional neural network, AIS = adenocarcinoma in situ, AUC = area under the
curve, C1= convolution 1, C2= convolution 2, CAD= computer-aided diagnosis, CI= conﬁdence interval, DL= deep learning, GGN
= ground-glass nodule, IVA = invasive adenocarcinoma, M1 = max pooling 1, M2 = max pooling 2, MIA = minimally invasive
adenocarcinoma, ROC = receiver operating characteristic.
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11. Introduction
CT has been widely used for qualitative and quantitative imaging
of lung cancer. Recent advances in CT techniques have enabled
the provision of thin-slice image data with high image quality
with a short period. As symbolized by the appearance of the term
“big data” in the mid-2000s, large amounts of data are now
easily obtained. In the medical ﬁeld, clinical data such as CT
images are constantly accumulating. Quick and efﬁcient extrac-
tion of valuable information from among large amounts of
clinical data is thus important. Computer-aided diagnosis (CAD)
systems have the potential to improve the clinical diagnostic
process by offering correct classiﬁcation decisions and volumetric
measurements, representing promising avenues for providing
accurate, reproducible quantiﬁcation of lung cancer.[1–3] Semi-
automatic and/or automatic differentiation between benign and
malignant tumors is one of the major tasks of CAD.[4–8]
However, many problems have to be overcome for CAD systems
in terms of the integration and selection of image features because
of the dependence on multiple image-processing tasks.[3,9]
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of deep learning algorithms, and the appearance of big data have
brought about a boom in tertiary artiﬁcial intelligence. Deep
learning (DL), structured by building a model to imitate the
human brain, is one of the artiﬁcial intelligence systems based on
neural networks. DL techniques are currently considered state of
the art for the classiﬁcation of images[10] and applied for some
ﬁelds of medical images.[11–14] The neural network begins by
simulating neural cells and trying to simulate the human brain
using a simulation model called a perceptron. A multilayer
perceptron is constructed by making and arranging layers with
perceptrons in which all nodes in the model are fully connected,
allowing the solution of more complicated problems. Artiﬁcial
intelligence technology has been applied in the ﬁeld of thoracic
imaging, and has developed in the following areas[15–30]:
detection of pulmonary nodules; differentiation between benign
and malignant lesions; diagnosis of diffuse lung diseases (i.e.,
retrieval system for resemble cases); and improvement of 3D-
analysis and image quality (e.g., Pixelshine, a noise-reduction
algorithm using machine learning; AlgoMedica, Sunnyvale, CA).
Lung adenocarcinoma is the most common histopathological
subtype of lung cancer. Early diagnosis of pathological
invasiveness using CT may alter the course of treatment of
adenocarcinomas and subsequently improve the prognosis.[21,22]
However, radiological prediction of pathological invasiveness is
very difﬁcult. Moreover, to the best of our knowledge, no CAD
systems have yet been shown to predict pathological invasiveness.Figure 1. Flowchart of patien
2Under the hypothesis thatDLmight be able to predict pathological
invasiveness, DL intended to be capable of such prediction was
developed in cooperationwith the department of technology inour
institution. The purpose of our study was to compare results for
radiological prediction of pathological invasiveness in lung
adenocarcinoma between radiologists and DL.2. Materials and methods
2.1. Study population
This study was approved by the internal ethics review board at
our institute. The need to obtain informed consent for this
retrospective review of patient records and images and the use of
patient biomaterials was waived in this study. Consecutive 90
patients (50 men, 40 women; mean age, 66 years; range, 40–88
years) with 90 nodules who had undergone surgery at our
institution between 2009 and 2011 were included (Fig. 1). All
patients had undergone preoperative thin-section CT of the chest.
Patients who had received previous treatments of the lungs or
other organs were excluded from the study. Patients with
histological subtypes other than adenocarcinoma were also
excluded.
Pathological diagnoses were made by 2 independent pathol-
ogists according to the 2015 World Health Organization
(WHO) Classiﬁcation of lung tumors[23] as adenocarcinoma in
situ (AIS), minimally invasive adenocarcinoma (MIA), ort population in the study.
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MIA, and IVA were conﬁrmed by consensus decisions.2.2. CT protocols
Ninety patients underwent scanning using a 64-channel multi-
detector-row CT scanner (Discovery CT750HD; GEHealthcare,
Milwaukee, WI) with the following protocols: detector collima-
tion, 0.625mm; detector pitch, 0.984; gantry rotation period, 0.4
seconds; matrix size, 512512 pixels; X-ray voltage, 120 kVp;
tube current, auto exposure control (mA); ﬁeld of view, 34.5cm
for full lung; high-resolution mode with 2496 views per rotation.
All targeted lung CT images were reconstructed using a 20-cm
ﬁeld of view from thin-section CT images reconstructed with a
high spatial frequency algorithm at 0.625-mm thicknesses using a
30% adaptive statistical iterative reconstruction.2.3. Subjective evaluation by radiologists
Three chest radiologists (AH [R1], NK [R2], andOH [R3], with 8,
9, and 26 years of experience, respectively) were instructed only to
evaluate each nodule. They independently diagnosed each nodule
by predicting pathological invasiveness from CT ﬁndings on a 21-
inch monochrome liquid crystal display monitor without prior
knowledge of histopathological diagnoses. CT ﬁndings were
classiﬁed according to previously reported criteria[24–31]: irregular
margin; air bronchogramwith disruption and/or irregular dilata-
tion; pleural indentation; and solid component in a part-solid
nodule (size  5mm or>5mm). In cases of ground-glass nodule
(GGN), nodule density (dense or inhomogeneous) was evaluatedFigure 2. Three-dimensional convolutional neural network (3D-CNN) structure. Th
extraction was constructed using 2 successive pairs of convolution (C1 and C2) a
layers. The ﬁrst 8000 fully connected layers were classiﬁed into 3 nodes (AIS, or
invasive adenocarcinoma, MIA=minimally invasive adenocarcinoma.
3according to the previous report[27]: dense GGN, with CT value
>400 Hounsﬁeld unit; and inhomogeneous GGN, complicated
distribution of solid-like portions. Final diagnosis (i.e., AIS, or
MIA, or IVA) was decided comprehensively according to these CT
ﬁndings.Nodule distribution (GGN,part-solidGGN, and solid) of
90 nodules was decided by consensus. Total nodule size and solid
component sizeweremeasuredby the principal investigator (M.Y.,
with 17 years of experience).2.4. Objective evaluation by the deep learning
DL with a 3-dimensional (3D)-convolutional neural network
(CNN) was used in the present study. TensorﬂowTM (version
0.12.1, Google Inc., Mountain View, CA) was used as the DL
framework. The 3D CT images including a nodule and a
surrounding normal lung parenchyma were classiﬁed by the 3D-
CNN. Input data size was 303030 voxels (11.7-mm cube in
real space). The 3D-CNN structure was constructed with 2
successive pairs of convolution (C1 and C2) and max-pooling
layers (M1 andM2), and 2 fully connected layers (Fig. 2). Kernel
sizes were 333 voxels (C1), 222 voxels (M1), 222
voxels (C2), and 333 voxels (M2). Numbers of convolution
ﬁlters were 32 and 64 for each convolution layer (C1 and C2),
respectively. The number of nodes in the ﬁrst fully connected
layer was 8000. The output layer comprised 3 nodes to recognize
the 3 conditions of adenocarcinoma (AIS, or MIA, or IVA), or 2
nodes for 2 conditions (AIS or MIA/IVA). A rectiﬁed linear unit
(ReLU) was used for the activation function in layers other than
the output layer. A softmax function was used for converting
output values to probabilities in the output layer. The CT imagese 3D-CNN structure consisted of feature extraction and classiﬁcation. Feature
nd max-pooling layers (M1 and M2). The classiﬁcation was of 2 fully connected
MIA, or IVA) or 2 nodes (AIS or MIA/IVA). AIS=adenocarcinoma in situ, IVA=
Table 1
Total nodule size and solid component size for each nodule type.
Total nodule size Solid component size
Nodule type Histology N (mean±SD, range) [mm] (mean±SD, range) [mm]
GGN AIS 16 16.3±6.3, 7–29 0
MIA 3 15.7±11.2, 6–28 0
IVA 5 17.6±2.4, 15–21 0
Part-solid AIS 8 18.0±6.3, 9–26 7.1±3.1, 3–12
MIA 12 19.3±4.8, 13–27 9.3±3.9, 4–16
IVA 20 24.7±4.8, 14–30 17.6±6.5, 8–27
Solid AIS 0 N/A N/A
MIA 5 14.6±5.5, 6–20 14.6±5.5, 6–20
IVA 21 20.1±6.4, 9–30 20.1±6.4, 9–30
AIS= adenocarcinoma in situ, GGN=ground-glass nodule, IVA= invasive adenocarcinoma, MIA=minimally invasive adenocarcinoma, SD= standard deviation.
Table 2
Pathological diagnostic accuracy rates among observers.
Differentiation among AIS, MIA, and IVA
Yanagawa et al. Medicine (2019) 98:25 Medicineof95nodules (25 cases ofAIS, 20 cases ofMIA, and50 cases of IVA)
scanned under the same conditions were divided into cases of
training data, 85 and test data, 10. To predict pathological
invasiveness, 9-fold cross-validation was performed on 90 cases of
CT image data (Fig. 1). In each training and prediction process, data
was augmented by adding some noise to 85 cases of training data.
2.5. Statistical analyses
The following statistical analyses were performed using com-
mercially available software (MedCalc version 13.1.2.0, 64 bit;
Frank Schoonjans, Mariakerke, Belgium). Accuracy rates among
DL and the 3 radiologists were statistically analyzed using
repeated-measures analysis of variance, conducted with Bonfer-
roni correction applied for multiple comparisons. A receiver
operating characteristic (ROC) analysis was used to determine
area under the curves (AUC) of DL and the 3 radiologists,
respectively: each CT diagnostic performance (i.e., 0=AIS, 1=
MIA/IVA) in DL and the 3 radiologists was used as a variable,
and each pathological diagnosis (i.e., 0=pathological AIS, 1=
pathological MIA/IVA) was used as a classiﬁcation variable.
Multivariate ROC analysis was performed to determine the
statistical signiﬁcance of the difference among 4 AUCs (DL and
the 3 radiologists). The additional statistical analysis was
performed using commercially available software (R version
3.4.1, 64 bit; R Core Team, Vienna, Austria [https://www.R-
project.org/]). Sensitivity and speciﬁcity among DL and the
consensus result of radiologists were compared using the
McNemar test with Bonferroni correction. Corrected values of
P<.05 were considered signiﬁcant.Observer Diagnostic accuracy rates 95% conﬁdence interval
DL 46/90 (51) 40.58–61.64
R1 55/90 (61) 42.83–63.84
R2 48/90 (53) 50.84–71.38
R3 58/90 (64) 54.36–74.53
Differentiation between AIS and MIA/IVA
Observer Diagnostic accuracy rates 95% conﬁdence interval
DL 66/90 (73) 64.02–82.65
R1 72/90 (80) 71.58–88.42
R2 67/90 (74) 65.26–83.63
R3 75/90 (83) 75.48–91.18
AIS=adenocarcinoma in situ, DL=deep learning, IVA= invasive adenocarcinoma, MIA=minimally
invasive adenocarcinoma, R1= radiologist with 8 years of experience, R2= radiologist with 9 years of
experience, R3= radiologist with 26 years of experience.
Figures in parentheses show percent.3. Results
3.1. Demographics of our study population
Final study population for subjective evaluations by radiologists
included 90 patients with 90 nodules (Fig. 1). Nine data set
groups were created from 95 patients: each data set group
consisted of training data, 85 and test data, 10. As a result of 9-
fold cross-validation, the diagnostic performance of DL for
pathological invasiveness in 90 nodules was obtained. The same
90 nodules were evaluated by each radiologist. Nodule
distribution of 90 nodules was as follows: 24 cases of GGN,
40 cases of part-solid GGN, and 26 cases of solid nodule. The
relationship between nodule type and histopathological results is
summarized in Table 1. GGN and part-solid GGN included all4histological subtypes. Solid nodules included only MIA and IVA.
Total nodule size and solid component size for each nodule type
are summarized in Table 1.3.2. Pathological diagnostic accuracy rates among DL and
the 3 radiologists
In differentiating among AIS, MIA, and IVA, no signiﬁcant
differences in pathological diagnostic accuracy rates were seen
among all observers (DL, R1, R2, and R3; P>.105). Results are
summarized in Table 2. In 11 cases, only DL could accurately
differentiate among AIS (n=4), MIA (n=6), and IVA (n=1)
(Fig. 3). The 4 cases of AIS comprised 1 GGN and 3 part-solid
GGNs, and the 6 cases of MIA comprised 5 part-solid GGNs and
1 solid nodule. The case of IVA represented GGN.
Similarly, in differentiation between AIS (without pathological
invasiveness) and MIA/IVA (with pathological invasiveness), no
signiﬁcant differences in pathological diagnostic accuracy rates
were evident among all observers (DL, R1, R2, and R3)
(P>.120). Results are summarized in Table 2.3.3. Diagnostic performance: differentiation between AIS
and MIA/IVA
Results of multivariate ROC analyses were as follows: the AUC
for DL, 0.712 (95% conﬁdence interval [CI], 0.607–0.803); for
Figure 3. Cases in which only the DL system could achieve accurate diagnosis. Pathologic diagnosis of AIS was made using hematoxilin and eosin stain (A-1) and
elastica-van Gieson stain (A-2). Only the DL system could diagnose this part-solid GGN (total nodule size, 9mm; solid component size, 3mm) as AIS (A-3). All
radiologists misdiagnosed the lesion as MIA. Pathologic diagnosis of MIA was made using hematoxilin and eosin stain (B-1) and elastica-van Gieson stain (B-2).
Only the DL system could diagnose this part-solid GGN (total nodule size, 20mm; solid component size, 12mm) as MIA (B-3). All radiologists misdiagnosed the
lesion as IVA. Pathologic diagnosis of IVA wasmade using hematoxilin and eosin stain (C-1) and elastica-van Gieson stain (C-2). Only the DL system could diagnose
this GGN (total nodule size, 17mm) as IVA (C-3). All radiologists misdiagnosed the lesion as AIS or MIA. AIS=adenocarcinoma in situ, GGN=ground-glass nodule,
IVA= invasive adenocarcinoma, MIA=minimally invasive adenocarcinoma.
Yanagawa et al. Medicine (2019) 98:25 www.md-journal.comR1, 0.665 (95% CI, 0.557–0.761); for R2, 0.574 (95% CI,
0.465–0.678); and for R3, 0.714 (95% CI, 0.609–0.804). The
AUC (0.712) for DL was almost the same as that (0.714) for the
most experienced radiologist (R3; P= .983), who had a signiﬁ-
cantly higher AUC than the radiologist with the least amount of
experience (R2; P= .026). Compared with the consensus result for
radiologists, DL offered signiﬁcantly inferior sensitivity (P
= .0005), but signiﬁcantly superior speciﬁcity for diagnosing the
invasiveness of adenocarcinoma (P= .02) (Table 3).4. Discussion
This study has shown that regardless of the small training data
set, diagnostic performance of DL was almost the same as that of
the most experienced radiologist, who showed a signiﬁcantly
higher AUC than the radiologist with the least amount of5experience. In particular, although the sensitivity of DL was
inferior to that of radiologists, DL provided higher speciﬁcity for
diagnosing the invasiveness of adenocarcinoma than radiologists.
In the present study, DL more accurately suggested the
percentage of adenocarcinomas correctly identiﬁed as not having
pathological invasiveness. If many more learning cases could be
used as training data, the likelihood that the performance of DL
will exceed that of human beings seems extremely high.
CAD systems can allow radiologists to quantitatively analyze
imaging data but work on the basis of differing algorithms for
feature extraction, selection, and integration, affecting the
differentiating abilities of each CAD system. Moreover, compli-
cated and laborious processes are needed to improve the
performance of CAD systems. On the other hand, particularly
in terms of image recognition, DL systems based on the CNN
structure with convolution and max-pooling layers can provide
Table 3
Diagnostic performance among observers: sensitivity and
speciﬁcity.
Observer
Point
estimate
95% conﬁdence
interval
R1 Sensitivity 0.955 0.873, 0.991
Speciﬁcity 0.375 0.188, 0.594
R2 Sensitivity 0.939 0.852, 0.983
Speciﬁcity 0.208 0.071, 0.422
R3 Sensitivity 0.970 0.895, 0.996
Speciﬁcity 0.458 0.256, 0.672
DL Sensitivity
∗
0.758 0.636, 0.855
Speciﬁcity #0.667 0.447, 0.844
The consensus result
of radiologists
Sensitivity
∗
0.970 0.895, 0.996
Speciﬁcity #0.292 0.126, 0.511
DL=deep learning, R1= radiologist with 8 years of experience, R2= radiologist with 9 years of
experience, R3= radiologist with 26 years of experience.
∗
The sensitivity of DL was signiﬁcantly inferior to the consensus result of radiologists (P= .0005).
# The speciﬁcity of DL was signiﬁcantly superior to the consensus result of radiologists (P= .02).
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ness) without using speciﬁc algorithms. In the present study, our
DL system easily achieved an accuracy rate almost identical to
that of radiologists in differentiating not only between AIS, MIA,
and IVA but also between AIS and MIA/IVA. Although no
signiﬁcant differences in pathological diagnostic accuracy rates
were seen among all observers (DL, R1, R2, and R3), high
dimensional image data from pixel data to whole-image data
could be processed within a few seconds simply by inputting
image data into the DL system. Unlike radiologists, the extreme
and growing processing power represents a key advantage of DL
systems.
In diagnostic performance to differentiate between AIS and
MIA/IVA, the AUC for the DL system was almost the same as
that for the most experienced radiologist, who in turn displayed a
signiﬁcantly higher AUC than the radiologist with the least
amount of experience. In previous studies into diagnoses for lung
cancer,[15,16] CAD systems using DL techniques were demon-
strated to offer superior diagnostic accuracy of lung cancer and
superior feature extraction for diagnosing pulmonary nodule
compared to conventional CAD. In the future, malignancy
diagnosis and prognostic prediction using DL systems may be
incorporated into our clinical setting. In our study, however,
compared with radiologists, DL showed signiﬁcantly inferior
sensitivity, but signiﬁcantly superior speciﬁcity. DL has the
possibility of correctly identifying adenocarcinoma without
pathological invasiveness. This result may be due to the fact
that only DL could accurately predict pathological diagnoses that
were sometimes difﬁcult for radiologists to differentiate. Higher
speciﬁcity of DL might suppress overdiagnoses of radiologists,
resulting in a positive effect on the management or treatment
strategies. Identifying subgroups of patients without pathological
invasiveness might be helpful in selecting patients suitable for
watchful waiting. Generally, DL systems are functionally black
boxes, meaning that the process by which a DL reaches a
conclusion is unknown. One possible reason was that given the
small number of cases, the cancer characteristics used as training
data happened to be consistent with those only DL can capture.
In other words, DL may not have always captured the essential
features of cancer in this study. Further analysis using a larger
cohort is needed to validate our results.6DL systems will provide useful and informative results, but
may not provide a useful alternative for clinicians. DL systems do
not have the ability to manage and decide treatment strategies,
but it is very important for radiologists to be able to beneﬁcially
utilize the information from DL systems. The combination of
radiologists and DL should preferably be superior to DL alone. In
fact, DL systems can provide useful results for nodule
detection,[32] and a deep 3D CNN could achieve high nodule
detection sensitivity even at 0.25 false-positive results per scan.
However, differentiation between benign and malignant lesions
may not necessarily be satisfactory results. Basically, radiologists
often diagnose pulmonary nodules by morphologically evaluat-
ing the margins and internal characteristics according to previous
data.[24–31] Naturally, limitations to diagnostic performance
exist. For example, localized GGN included all pathological
subtypes of adenocarcinoma.[33] However, some radiologists
might not be able to accurately differentiate IVA from GGN on
CT images. Therefore, unlike nodule detection, in differentiating
between benignancy and malignancy, some cases might be
encountered in which a DL system identiﬁes malignant lesions
that the radiologist cannot believe or verify. Much higher
accuracy, sensitivity, and speciﬁcity are thus needed for DL to
contribute to the diagnosis of malignancy.
Our study shows several limitations. First, the biggest
limitation is the small dataset. Overﬁtting is thus one of the
disadvantages to DL, which may be more prominent in cases
with a small number of training samples. Our DL system ﬁt the
present study data well but might not generalize well to unseen
cases. Further studies using a larger training data set are needed
to validate our results. Second, our study was retrospective, and
selection bias was thus inevitable. Third, only primary sites
were evaluated. If data for lymph node metastases and lung
tissues surrounding primary sites had been used for the
construction of DL systems, diagnostic performance might have
been inﬂuenced. Analysis of additional training cases would
have been interesting. Finally, 3D data from CT images were
analyzed using the DL system. However, not all cross-sections
from each pathological specimen could be evaluated in the
present study. Therefore, invasive components in pathological
specimens may not necessarily have represented the true
invasive component itself.
In conclusion, despite the small training data set, DL showed
an accuracy rate almost equal to that of radiologists. The AUC of
DL was almost the same as that of the radiologist with the most
experience, which in turn was signiﬁcantly higher than that of the
radiologist with the least experience. DL systems can predict
pathological invasiveness in lung adenocarcinoma from CT
images, particularly with high speciﬁcity. DL can provide useful
and informative results but does not replace the radiologist.
Likewise, DL does not have the ability to manage or decide
treatment strategies, so radiologists need to intelligently use the
information derived from DL. We expect that radiologists will
play important roles in developing and using artiﬁcial intelligence
technologies.Author contributions
Conceptualization: Masahiro Yanagawa, Hirohiko Niioka.
Data curation: Masahiro Yanagawa, Akinori Hata, Noriko
Kikuchi, Osamu Honda.
Formal analysis: Masahiro Yanagawa, Hirohiko Niioka,
Hiroyuki Kurakami, Eiichi Morii, Masayuki Noguchi.
Yanagawa et al. Medicine (2019) 98:25 www.md-journal.comInvestigation: Masahiro Yanagawa, Hirohiko Niioka, Akinori
Hata, Noriko Kikuchi, Osamu Honda, Hiroyuki Kurakami,
Eiichi Morii, Masayuki Noguchi, Yoshiyuki Watanabe.
Methodology:Masahiro Yanagawa, Hirohiko Niioka, Hiroyuki
Kurakami, Yoshiyuki Watanabe, Jun Miyake, Noriyuki
Tomiyama.
Project administration: Masahiro Yanagawa.
Software: Masahiro Yanagawa, Hirohiko Niioka.
Supervision: Masahiro Yanagawa, Eiichi Morii, Masayuki
Noguchi, Yoshiyuki Watanabe, Jun Miyake, Noriyuki
Tomiyama.
Validation: Masahiro Yanagawa, Hirohiko Niioka.
Visualization: Masahiro Yanagawa, Hirohiko Niioka, Eiichi
Morii, Masayuki Noguchi.
Writing – original draft: Masahiro Yanagawa.
Writing – review & editing: Jun Miyake, Noriyuki Tomiyama.
References
[1] Yankelevitz DF, Reeves AP, Kostis WJ, et al. Small pulmonary nodules:
volumetrically determined growth rates based on CT evaluation.
Radiology 2000;217:251–6.
[2] Wormanns D, Kohl G, Klotz E, et al. Volumetric measurements of
pulmonary nodules at multi-row detector CT: in vivo reproducibility.
Eur Radiol 2004;14:86–92.
[3] Goo JM. A computer-aided diagnosis for evaluating lung nodules on
chest CT: the current status and perspective. Korean J Radiol
2011;12:145–55.
[4] Yanagawa M, Tanaka Y, Kusumoto M, et al. Automated assessment of
malignant degree of small peripheral adenocarcinomas using volumetric
CT data: correlation with pathologic prognostic factors. Lung Cancer
2010;70:286–94.
[5] de Hoop B, Gietema H, van de Vorst S, et al. Pulmonary ground-glass
nodules: increase in mass as an early indicator of growth. Radiology
2010;255:199–206.
[6] Naidich DP, Bankier AA,MacMahon H, et al. Recommendations for the
management of subsolid pulmonary nodules detected at CT: a statement
from the Fleischner Society. Radiology 2013;266:304–17.
[7] Yanagawa M, Tanaka Y, Leung AN, et al. Prognostic importance of
volumetric measurements in stage I lung adenocarcinoma. Radiology
2014;272:557–67.
[8] Colombi D, Manna C, Montermini I, et al. Semiautomatic analysis on
computed tomography in locally advanced or metastatic non-small cell
lung cancer: reproducibility and prognostic signiﬁcance of unidimensional
and 3-dimensional measurements. J Thorac Imaging 2015;30:290–9.
[9] Way TW, Sahiner B, Chan HP, et al. Computer-aided diagnosis of
pulmonary nodules on CT scans: improvement of classiﬁcation
performance with nodule surface features. Med Phys 2009;36:3086–98.
[10] Russakovsky O, Deng J, Su H, et al. Imagenet large scale visual
recognition challenge. Int J Comput Vis 2015;115:211–52.
[11] Esteva A, Kuprel B, NovoaRA, et al. Darmatologist-level classiﬁcation of
skin cancer with deep neural networks. Nature 2017;542:115–8.
[12] Kermany DS, Goldbaum M, Cai W, et al. Identifying medical diagnoses
and treatable diseases by image-based deep learning. Cell 2018;172:
1122–31.
[13] Bejnordi BE, Beta M, Diest PJ, et al. Diagnostic assessment of deep
learning algorithms for detection of lymph node metastases in women
with breast cancer. JAMA 2017;318:2199–210.7[14] Niioka H, Asatani S, Yoshimura A, et al. Classiﬁcation of C2C12 cells at
differentiation by convolutional neural network of deep learning using
phase contrast images. Hum Cell 2018;31:87–93.
[15] SunW, Zheng B, QianW. Automatic feature learning usingmultichannel
ROI based on deep structured algorithms for computerized lung cancer
diagnosis. Comput Biol Med 2017;289:530–9.
[16] Hua KL, Hsu CH, Hidayati SC, et al. Computer-aided classiﬁcation of
lung nodules on computed tomography images via deep learning
technique. Onco Targets Ther 2015;8:2015–22.
[17] Labaki WW, Han MK. Artiﬁcial intelligence and chest imaging. Will
deep learning make us smarter. Am J Respir Crit Care Med
2018;197:148–50.
[18] Lakhani P, Sundaram B. Deep learning at chest radiography: automated
classiﬁcation of pulmonary tuberculosis by using convolutional neural
networks. Radiology 2017;284:574–82.
[19] Bar Y, Diamant I,Wolf L, GreenspanH. Deep learning with non-medical
training used for chest pathology identiﬁcation. In: Hadjiiski LM,
Tourassi GD, eds. Proceedings of SPIE: medical imaging 2015–
computer-aided diagnosis. Vol 9414. Bellingham, Wash: International
Society for Optics and Photonics, 2015; 94140 V.
[20] Shin HC, Roth HR, Gao M, et al. Deep convolutional neural networks
for computeraided detection: CNN architectures, dataset characteristics
and transfer learning. IEEE Trans Med Imaging 2016;35:1285–98.
[21] Maeshima AM, Tochigi N, Yoshida A, et al. Histological scoring for
small lung adenocarcinomas 2cm or less in diameter: a reliable
prognostic indicator. J Thorac Oncol 2010;5:333–9.
[22] Tsutani Y, Miyata Y, Mimae T, et al. The prognostic role of pathologic
invasive component size, excluding lepidic growth, in stage I lung
adenocarcinoma. J Thorac Cardiovasc Surg 2013;146:580–5.
[23] Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health
Organization classiﬁcation of lung tumors: impact of genetic, clinical and
radiologic advances since the 2004 classiﬁcation. J Thorac Oncol
2015;10:1243–60.
[24] Stroom J, Blaauwgeers H, van Baardwijk A, et al. Feasibility of
pathology-correlated lung imaging for accurate target deﬁnition of lung
tumors. Int J Radiat Oncol Biol Phys 2007;69:267–75.
[25] Macpherson RE, Higgins GS, Murchison JT, et al. Non-small-cell lung
cancer dimensions: CT-pathological correlation and interobserver
variation. Br J Radiol 2009;82:421–5.
[26] Lee SM, Goo JM, Lee KH, et al. CT ﬁndings of minimally invasive
adenocarcinoma (MIA) of the lung and comparison of solid portion
measurementmethods at CT in 52 patients. Eur Radiol 2015;25:2318–25.
[27] Yanagawa M, Johkoh T, Noguchi M, et al. Radiological prediction of
tumor invasiveness of lung adenocarcinoma on thin-section CT.
Medicine (Baltimore) 2017;96:e6331.
[28] Lim HJ, Ahn S, Lee KS, et al. Persistent pure ground-glass opacity lung
nodules ≥ 10mm in diameter at CT scan:histopathologic comparisons
and prognostic implications. Chest 2013;144:1291–9.
[29] Lampen-Sachar K, Zhao B, Zheng J, et al. Correlation between tumor
measurement on computed tomography and resected specimen size in
lung adenocarcinomas. Lung Cancer 2012;75:332–5.
[30] Kakinuma R, Noguchi M, Ashizawa K, et al. Natural history of
pulmonary subsolid nodules: a prospective multicenter study. J Thorac
Oncol 2016;11:1012–28.
[31] Nakamura H, Saji H, Ogata A, et al. Lung cancer patients showing pure
ground-glass opacity on computed tomography are good candidates for
wedge resection. Lung Cancer 2004;44:61–8.
[32] Jin H, Li Z, Tong R, et al. A deep 3D residual CNN for false-positive
reduction in pulmonary nodule detection. Med Phys 2018;45:2097–107.
[33] She Y, Zhao L, Dai C, et al. Preoperative nomogram for identifying
invasive pulmonary adenocarcinoma in patients with pure ground-glass
nodule: a multi-institutional study. Oncotarget 2017;8:17229–38.
